Company: PTPI
Filing Date: 2025-03-14
Form Type: PRER14A
Source: 0001104659-25-024012
Chunk: 85

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-14
Form: PRER14A
Chunk 85
---
 relevant date
or, if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Common Stock is
not principally traded on any such exchange, the last reported sale price of a share of Common Stock during regular trading hours on
the relevant date, as reported by the OTC Bulletin Board.

(ii) If
the Common Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair
Market Value per share shall be determined by the Committee through any reasonable valuation method authorized under the Code, including,
without limitation section 409A of the Code.

(t) “” shall mean an Option that is intended to meet the requirements of an incentive stock option under section 422
of the Code.

(u)
“” shall mean a consultant or advisor of the Employer.

(v)
“” shall mean a member of the Board who is not an Employee.

(w) “” shall mean an Option that is not intended to be taxed as an incentive stock option under section 422 of the Code.

(x) “”
shall mean an option to purchase shares of Common Stock, as described in Section 6.

(y) “” shall mean any Award based on, measured by or payable in Common Stock (other than an Option, Stock Unit,
Stock Award, or SAR), as described in Section 10.

(z) “”
shall mean an Employee, Key Advisor or Non-Employee Director designated by the Committee to participate in the Plan.

<div align='center'>C-3</div>

(aa) “” shall mean the performance objectives established in the sole discretion of the Committee for Participants who
are eligible to receive Awards under the Plan. Performance Objectives may be described in terms of Company-wide objectives or objectives
that are related to the performance of the individual Participant or the subsidiary, division, department or function within the Company
or one of its subsidiaries in which the Participant is employed. Performance Objectives may be measured on an absolute or relative basis.
Relative performance may be measured by a group of peer companies or by a financial market index. Any Performance Objectives may include:
specified levels of or increases in the Company’s, a division’s or a subsidiary’s return on capital, equity or assets;
earnings measures/ratios (on a gross, net, pre-tax or post-tax basis), including basic earnings per share, diluted earnings per share,
total earnings, operating earnings, earnings growth, earnings before interest and taxes and